Cargando…
Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase
Afatinib, used for the first-line treatment of non-small-cell lung carcinoma (NSCLC) patients with distinct epidermal growth factor receptor (EGFR) mutations, inactivates EGFR by mimicking ATP structure and forming a covalent adduct with EGFR. We developed a method to unravel potential targets of af...
Autores principales: | Yu, Cheng-Han, Chou, Chi-Chi, Tu, Hsin-Fang, Huang, Wei-Chieh, Ho, Ya-Yeh, Khoo, Kay-Hooi, Lee, Ming-Shyue, Chang, Geen-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940374/ https://www.ncbi.nlm.nih.gov/pubmed/29765556 http://dx.doi.org/10.18632/oncotarget.25177 |
Ejemplares similares
-
Convergent allostery in ribonucleotide reductase
por: Thomas, William C., et al.
Publicado: (2019) -
The periodic table of ribonucleotide reductases
por: Ruskoski, Terry B., et al.
Publicado: (2021) -
Hepatitis C Virus Down-Regulates the Expression of Ribonucleotide Reductases to Promote Its Replication
por: Yang, Chee-Hing, et al.
Publicado: (2023) -
The tyrosyl free radical in ribonucleotide reductase.
por: Gräslund, A, et al.
Publicado: (1985) -
Target identification reveals protein arginine methyltransferase 1 is a potential target of phenyl vinyl sulfone and its derivatives
por: Yu, Cheng-Han, et al.
Publicado: (2018)